TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 10.3nMpH: 7.4 T: 2°CAssay Description:[3H]PDBu binding to the C1 domains of MRCK alpha/beta and PKC alpha/delta was measured using the polyethylene glycol precipitation assay.More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 25nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CDC42BPA (unknown origin) (1 to 574 residues) expressed in baculovirus inf...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 43nMAssay Description:Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CDC42BPA (unknown origin) (1 to 574 residues) expressed in baculovirus inf...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 57nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 57nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 57nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 380nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 660nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 1.30E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 1.80E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 1.80E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 1.80E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.00E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.00E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.00E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.60E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.60E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 2.60E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 6.20E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 6.20E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 6.20E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.20E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.40E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.40E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.40E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.50E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.50E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: 9.50E+3nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Homo sapiens (Human))
National Cancer Institute-Bethesda
National Cancer Institute-Bethesda
Affinity DataKd: >1.00E+4nMAssay Description:Binding constant for MRCKA kinase domainMore data for this Ligand-Target Pair